Drug Approval | July 01, 2022
Zydus receives final approval from USFDA for Lacosamide injection
Lacosamide Injection is used to treat partial-onset seizures.
Lacosamide Injection is used to treat partial-onset seizures.
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia
It is a two dose vaccine to be administered intramuscularly at 28 days apart
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional doses
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Strengthens investment in channels of the future to expand patient reach
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
Subscribe To Our Newsletter & Stay Updated
